Trial Profile
A prospective study to evaluate the efficacy and safety of brentuximab vedotin in patients with lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 11 May 2016 New trial record